Molecular Diagnostics: Page 2

AMDI receives $5.2M in RADx Tech funding for PCR viral testing system
By LabPulse.com staff writers
Autonomous Medical Devices Incorporated (AMDI) has received a U.S. National Institutes of Health (NIH) RADx Tech award of up to $5.2 million to finalize its rapid point-of-care viral testing system.
March 4, 2024
Money Bag Grant Award Social
Reversible, multiplex CRISPR system enhances efficacy of CAR-T cell therapy
By Nick Paul Taylor
A CRISPR system that uses Cas13d to make reversible changes to the expression of multiple genes could overcome limitations that are holding back CAR-T cell therapies, a paper published in Cell suggests.
February 28, 2024
Licensed under Creative Commons
Intellia Therapeutics, ReCode Therapeutics to collaborate on genomic medicines for CF
By LabPulse.com staff writers
Gene-editing firm Intellia Therapeutics and biotech company ReCode Therapeutics have entered into a strategic collaboration aimed at developing genomic medicines for the treatment of cystic fibrosis (CF).
February 16, 2024
Science Genome Sequence Dna Map Social
CRISPR and nanopore technology enable sensitive and specific mpox detection
By Nick Paul Taylor
A test that combines CRISPR gene editing and nanopore sensing technology could accelerate the detection of mpox and other pathogens, according to a paper published in Biosensors and Bioelectronics.
February 16, 2024
3 D Monkeypox Infecting Cell Social
High hopes for accurate blood test detecting malignant brain tumors
By Matt Limb
A simple blood test to detect malignant brain tumors that can be hard to locate could spare many cancer patients risky and invasive surgery, say scientists.
February 9, 2024
Blood Test Samples Lab Social
Twist Bioscience, Element Biosciences to collaborate on exome workflow
By LabPulse.com staff writers
Synthetic biology and genomics company Twist Bioscience and life science firm Element Biosciences have announced a collaboration to develop a dedicated workflow for Element’s AVITI system.
February 6, 2024
Test Tubes Social
U.K. Health Security Agency unveils five-year pathogen genomics strategy
By Matt Limb
The U.K. Health Security Agency (UKHSA) has unveiled a five-year plan to make pathogen genomics central to protecting public health and combating infectious disease threats.
February 1, 2024
Lab Microscope Slide Social
Blood test for Alzheimer’s shows high accuracy in study
By Matt Limb
Scientists have hailed study results showing the high accuracy of a blood test that “could revolutionize” diagnosis of Alzheimer’s disease.
January 31, 2024
Alzheimers Tau Tangles Social
Jury awards Natera $96.3M in patent infringement case against CareDX
By LabPulse.com staff writers
A jury in the U.S. District Court for the District of Delaware has ruled in favor of Natera in its patent infringement case against CareDx, awarding the firm approximately $96.3 million in damages in a unanimous verdict.
January 29, 2024
Gavel Money Social
Researchers ID potential predictive biomarkers for CVD in type 2 diabetes
By LabPulse.com staff writers
An analysis conducted by an international research team has identified 13 biomarkers that may improve the accuracy of predicting risk of cardiovascular disease (CVD) in people with type 2 diabetes.
January 25, 2024
Diabetes Woman Lancet Social
Precision medicine at tipping point with looming FDA LDT oversight
By Liz Carey
FDA targets companion diagnostics (CDx) LDTs first. In addition, CAP and AdvaMedDx set clear expectations, and what to know about the FDA-CMS joint statement on FDA oversight.
January 25, 2024
Fda Sign Dc Social
Sensorion receives clinical trial approval for congenital deafness gene therapy
By LabPulse.com staff writers
French biotech firm Sensorion has received approval to initiate a phase I and II clinical trial in France of SENS-501 (the OTOF-GT program), its gene therapy for gene-mediated hearing impairment.
January 22, 2024
Clinical Trial Data Network Social
Previous Page
Page 2 of 193
Next Page